Inventor

RAPTA MIROSLAV

US62 patents

⚠️ This page may combine multiple inventors who share the name “RAPTA MIROSLAV”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

RAPTA MIROSLAV

THERAVANCE BIOPHARMA R&D IP LLC

Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

(2R,4R)-5-(5′-Chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereof

JAK kinase inhibitor compounds for treatment of respiratory disease

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

THERAVANCE INC

Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity

Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

Crystalline forms of an 8-azabicyclo(3.2.1)octane compound

Crystalline form of a biphenyl compound

Crystalline form of a biphenyl compound

Crystalline forms of a dimethylphenyl compound

DALZIEL SEAN M

Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

Crystalline forms of a 3-carboxypropyl-aminotetralin compound

Crystalline forms of a 3-carboxypropyl-aminotetralin compound

Crystalline forms of a 3-carboxypropyl-aminotetralin compound

RAPTA MIROSLAV

Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid compound

Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid compound

Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid compounds

Crystalline form of (2S,4R)-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-4-[(1H-[1,2,3]triazole-4-carbonyl)-amino]-pentanoic acid 5-methyl-2-oxo-[1,3]dioxol-4-ylmethyl ester

STANGELAND ERIC L

Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

PATTERSON LORI JEAN

Crystalline form of a 4-[2-(2-fluorophenoxymethyl) phenyl]piperidine compound

Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

CHAO ROBERT S

Crystalline form of a biphenyl compound

Crystalline form of a biphenyl compound

COLSON PIERRE-JEAN

Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

SAITO DAISUKE ROLAND

Crystalline form of a 3-phenoxymethylpyrrolidine compound

DALZIEL SEAN

Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

TRAPP SEAN G

3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists